In agreement with these findings, cells for the favorable low-risk neuroblastoma case (K6, stage 4S, Supplementary Data 1) were homogeneously NTRK1+, TH+, NTRK2− (Supplementary Fig. 5a). The gene discussed is NTRK1; the disease is neuroblastoma.